Switching from CD44 variant isoforms containing exon v7 to isoform 4 without change in a total amount of CD44 was observed in human epithelial ovarian cancer cell line HO8910 with a stable suppression of ESRP1 expression (Chen et al., 2017). Here, CD44 is linked to ovarian carcinoma.